Effect of kidney transplantation on outcomes among patients with hepatitis C

Journal of the American Society of Nephrology

Volumn 22, Issue 6, 2011, Pages 1152-1160

  Roth, David ^a   Gaynor, Jeffrey J ^a   Reddy, K Rajender ^b   Ciancio, Gaetano ^a   Sageshima, Junichiro ^a   Kupin, Warren ^a   Guerra, Giselle ^a   Chen, Linda ^a   Burke III, George W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; INFECTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEIC ACID ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SURVIVAL; TREATMENT OUTCOME;

EID: 79957698663     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010060668     Document Type: Article

References (50)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton ML: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362, 1989 (Pubitemid 19117877)
2. Alter HJ, Seeff LB: Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Semin Liver Dis 20: 17-35, 2000 (Pubitemid 30421406)
3. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM: Relationship between hepatitis C and chronic kidney disease: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 17: 1168-1174, 2006
4. Pereira BJ, Levey AS: Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 51: 981-999, 1997 (Pubitemid 27186522)
5. Dalrymple LS, Koepsell T, Sampson J, Louie T, Dominitz JA, Young B, Kestenbaum B: Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol 2: 715-721, 2007
6. Fabrizi F, Pozzi C, Farina M, Dattolo P, Lunghi G, Badalamenti S, Pagano A, Locatelli F: Hepatitis C virus infection and acute or chronic glomerulonephritis: An epidemiological and clinical appraisal. Nephrol Dial Transplant 13: 1991-1997, 1998
7. Gumber SC, Chopra S: Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123: 615-620, 1995
8. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Coreu L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465-470, 1993 (Pubitemid 23056436)
9. D'Amico G: Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 54: 650-671, 1998
10. Sabry AA, Sobh MA, Irving WL, Grabowska A, Wagner BE, Fox S, Kudesia G, El Nahas M: A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 17: 239-245, 2002 (Pubitemid 34157137)
11. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 20: 1271-1277, 2004 (Pubitemid 40040073)
12. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Hepatitis C virus antibody status and survival after renal transplantation: Meta-analysis of observational studies. Am J Transplant 5: 1452-1461, 2005 (Pubitemid 40839438)
13. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjerston SW, Kopple JD, Greenland S: Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol 18: 1584-1593, 2007 (Pubitemid 46717526)
14. Pereira BJ, Natov SN, Bouthot BA, Murthy BVR, Ruthhazer R, Schmid CH, Levey AS: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 53: 1374-1381, 1998 (Pubitemid 28316901)
15. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 32: 629-634, 1998 (Pubitemid 28477710)
16. Kidney disease: Improving global outcomes. KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 73[Suppl 109]: S1-S99, 2008
17. Kenny-Walsh E: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin: Irish Hepatology Research Group. N Engl J Med 340: 1228-1233, 1999
18. Seeff LB: Natural history of chronic hepatitis C. Hepatology 36: S35-S46, 2002
19. Hoofnagle JH, Seeff LB: Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 355: 2444-2451, 2006 (Pubitemid 44903748)
20. McHutchison JG, Gordon SC, Schiff ER, Schiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling M-H, Cort S, Albrecht JK, for the Hepatitis Interventional Therapy Group: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339: 1485-1492, 1998 (Pubitemid 28543496)
21. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcole J, Zeumen S, Trepo C, Albrecht J: Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352: 1426-1432, 1998 (Pubitemid 28510876)
22. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982, 2002
23. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
24. Hanafusa T, Ichikawa Y, Kishikawa H, Kyo MI, Fukunishi T, Kokado Y, Okuyama A, Shinji Y, Nagamo S: Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 66: 471-476,1998 (Pubitemid 28415373)
25. Legendre C, Garrigue V, Le Bihan C, Manzer-Bruneel MT, Chaix ML, Landais P, Kreis H, Pol S: Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 65: 667-670, 1998 (Pubitemid 28128936)
26. Luan FL, Schaubel DE, Zhang H: Jia X, Pettetier SJ, Port FK, Magee JC, Sung RS: Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation 85: 1601-1606, 2008
27. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy R: Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 5: 139-144, 2005 (Pubitemid 40095138)
28. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ: The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 29: 608-614, 1997 (Pubitemid 27155284)
29. Maluf DG, Fisher RA, King AL, Gibney EL, Mas VR, Coterell AH, Shiffman ML, Sterling RK, Behnke M, Posner MP: Hepatitis C virus infection and kidney transplantation: Predictors of patient and graft survival. Transplantation 83: 853-857, 2007 (Pubitemid 46682725)
30. Scientific Registry of Transplant Recipients. Available online at http://www.ustransplant.org/. Accessed September 22, 2010
31. Pereira BJ, Wright TL, Schmid CH, Levey AS: The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 60: 799-805, 1995
32. Batty DS Jr, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC: Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant 1: 179-184, 2001 (Pubitemid 33674159)
33. Martin P, Carter D, Fabrizi F, Dixit V, Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G: Histopathological features of hepatitis C in renal transplant candidates. Transplantation 69:1479-1484, 2000 (Pubitemid 30238744)
34. Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contros MJ, Schiffman ML: Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 94: 3576-3582, 1999
35. Caramelo C, Ortiz A, Aguilera B, Porres JC, Navas S, Marriott E, Alberola MC, Alamo C, Galera A, Garron MP: Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 22: 822-828, 1993 (Pubitemid 23353614)
36. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF: Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 94: 159-163, 1999 (Pubitemid 29063461)
37. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Garnot F, Berthelot P, Brechot C: Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 44: 1097-2000, 1993
38. Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med 345: 41-52, 2001 (Pubitemid 32634271)
39. Zylberberg H, Nalpas B, Carnot F: Skhiri H, Fontaine H, Legendre C, Kreis H, Brechot C, Pol S: Severe evolution of chronic hepatitis C in renal transplantation: A case control study. Nephrol Dial Transplant 17: 129-133, 2002 (Pubitemid 34093022)
40. Alric L, Di-Martino V, Selves J, Cacoub P, Charlotte F, Reynaud D, Piette J-C, Peron J-M, Vinel J-P, Durand D, Izopet J, Poynard T, Duffaut M, Rostaing L: Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology 123: 1494-1499, 2002 (Pubitemid 35231649)
41. Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durant D, Izopet J: Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 5: 1704-1712, 2005 (Pubitemid 40910453)
42. Nelson D, Soldevila-Pico C, Reed A, Abdelmalek MF, Hemming AW, van de Werf WJ, Howard R, Davis GL: Anti-interleukin-2 receptor therapy in combination with mycophenolate is associated with more severe hepatitis C recurrence after liver transplantation. Liver Transplant 7: 1064-1070, 2001 (Pubitemid 34023993)
43. Hanuka N, Sikuler E, Tovbin D, Mostoslavsky M, Hausman M, Orgel M, Years A, Shemer-Avni Y: Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat 9: 141-145, 2002 (Pubitemid 36002478)
44. Garinis G, Spanakis N, Theodorou V, Manolis E, Karameris A, Valis D: Comparison of the enzyme-linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients. J Clin Lab Anal 13: 122-125, 1999 (Pubitemid 29207137)
45. Ciancio G, Burke GW, Suzart K, Roth D, Kupin W: Rosen A, Olson L, Esquanazi V, Miller J: Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. Transplantation 73: 1100-1106, 2002 (Pubitemid 34415442)
46. Ciancio G, Burke G, Gaynor J, Ruiz P, Roth D, Kupin W, Rosen A, Miller J: A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporine/sirolimus in renal transplantation: Three-year analysis. Transplantation 81: 845-852, 2006
47. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293, 1996 (Pubitemid 26260021)
48. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data, New York, John Wiley and Sons, 1980
49. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA 270: 1339-1343, 1993 (Pubitemid 23267894)
50. Mauger EA, Wolfe RA, Port F: Transient effects in the Cox proportional hazards regression model. Stat Med 14: 1553-1565, 1995